NuCana (NCNA) Net Cash Flow (2017 - 2025)
NuCana's (NCNA) quarterly Net Cash Flow came in at -$1.3 million in Q4 2025, up 80.07% year-on-year from -$745323.1 in Q4 2024, and down 106.0% quarter-over-quarter from $22.4 million in Q3 2025.
NuCana (NCNA) Net Cash Flow (2017 - 2025) Analysis & Trends
NuCana has disclosed Net Cash Flow across 9 years of filings, most recently posting -$1.3 million for Q4 2025.
- Net Cash Flow for Q4 2025 came in at -$1.3 million, up 80.07% year-over-year; the trailing twelve-month figure through Dec 2025 was $21.0 million (up 251.98% YoY), and the FY2025 annual result was $23.3 million, up 268.17% from the prior year.
- Net Cash Flow came in at -$1.3 million for Q4 2025 at NuCana, down from $22.4 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $22.4 million in Q3 2025 to a low of -$16.2 million in Q4 2022.
- The 5-year median for Net Cash Flow is -$6.9 million (2024), against an average of -$5.4 million.
- Across the five-year window, Net Cash Flow tumbled 8000.1% in 2024 and jumped 18821.79% in 2025, its largest moves.
- NuCana's Net Cash Flow stood at -$14.3 million in 2021, then decreased by 13.15% to -$16.2 million in 2022, then soared by 99.49% to -$83157.2 in 2023, then sank by 8000.1% to -$6.7 million in 2024, then surged by 80.07% to -$1.3 million in 2025.
- The last three Net Cash Flow figures came in at -$1.3 million (Q4 2025), $22.4 million (Q3 2025), and -$6.7 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 664,983.53 |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | -1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.34 Mn |
| Dec 31, 2025 | -1.34 Mn |
| Sep 30, 2025 | 22.37 Mn |
| Sep 30, 2025 | 22.37 Mn |
| Dec 31, 2024 | -6.74 Mn |
| Dec 31, 2024 | -6.74 Mn |
| Sep 30, 2024 | 118,236.32 |
| Sep 30, 2024 | 118,236.32 |
| Jun 30, 2024 | -1.57 Mn |
| Jun 30, 2024 | -1.57 Mn |
| Mar 31, 2024 | -5.65 Mn |
| Mar 31, 2024 | -5.65 Mn |
| Dec 31, 2023 | -83,157.18 |
| Dec 31, 2023 | -83,157.18 |
| Sep 30, 2023 | -9.45 Mn |
| Sep 30, 2023 | -9.45 Mn |
| Jun 30, 2023 | -7.33 Mn |
| Jun 30, 2023 | -7.33 Mn |
| Mar 31, 2023 | -12.41 Mn |
| Mar 31, 2023 | -12.41 Mn |